April 19, 2025 - 00:24

If we want to find a stock that could multiply over the long term, it’s essential to focus on specific underlying trends that indicate strong performance potential. One critical metric to consider is Return on Capital Employed (ROCE), which measures a company's efficiency in generating profits from its capital. A consistent or improving ROCE can signal that a company is effectively utilizing its resources to drive growth.
Investors should also pay attention to revenue growth rates and profit margins, as these factors contribute to overall financial health. A company that demonstrates robust revenue growth alongside stable or increasing profit margins is often better positioned to deliver long-term returns. Additionally, assessing the competitive landscape, technological advancements, and market demand can provide insights into a company's future prospects.
Ultimately, a combination of strong ROCE, healthy revenue growth, and favorable market conditions can create a compelling case for investors seeking stocks with significant long-term appreciation potential.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...